Related Experiment Video
Updated: Oct 29, 2025

Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material
Published on: August 1, 2018
The site of breast cancer metastases dictates their clonal composition and reversible transcriptomic profile
Jean Berthelet1,2, Verena C Wimmer3,4, Holly J Whitfield4,5
1Olivia Newton-John Cancer Research Institute, Heidelberg, VIC 3084, Australia. delphine.merino@onjcri.org.au jean.berthelet@onjcri.org.au.
Abstract:
Intratumoral heterogeneity is a driver of breast cancer progression, but the nature of the clonal interactive network involved in this process remains unclear. Here, we optimized the use of optical barcoding to visualize and characterize 31 cancer subclones in vivo. By mapping the clonal composition of thousands of metastases in two clinically relevant sites, the lungs and liver, we found that metastases were highly polyclonal in lungs but not in the liver. Furthermore, the transcriptome of the subclones varied according to their metastatic niche. We also identified a reversible niche-driven signature that was conserved in lung and liver metastases collected during patient autopsies. Among this signature, we found that the tumor necrosis factor-α pathway was up-regulated in lung compared to liver metastases, and inhibition of this pathway affected metastasis diversity. These results highlight that the cellular and molecular heterogeneity observed in metastases is largely dictated by the tumor microenvironment.

